Smart pills dumb down medical care, experts warn

September 21, 2018 by Jacqueline Carey, University of Illinois at Chicago
Eric Swirsky. Credit: UIC

Enthusiasm for an emerging digital health tool, the smart pill, is on the rise but researchers at the University of Illinois at Chicago have published a paper in the American Journal of Bioethics that cautions health care providers and policymakers to slow down when it comes to allowing this technology in patient care settings.

Smart pills, or digital pills, are prescription medications equipped with edible electronic sensors that send wireless messages to devices, like patches and smartphones or tablets, outside the body when they are ingested. The first of its kind, which is used to treat with schizophrenia, bipolar disorder and major depressive disorder, was approved for use in humans by the U.S. Food and Drug Administration in 2017.

Some hope the technology will help patients and doctors track drug regimen compliance and increase patient adherence, which estimates show may save between $100 and $300 billion annually in the U.S. Others have concerns about patient privacy, consent and data sharing.

Eric Swirsky, an expert in the legal and ethical issues related to technology, says that both groups have valid arguments but that neither is asking the right question.

"We need to know if smart pills are going to actually improve patients' lives, which is much more complicated than compliance or privacy," said Swirsky, clinical associate professor of biomedical and health information sciences in the UIC College of Applied Health Sciences. "It is naive to think that this type of surveilled compliance with provider-recommended drug treatments will function like a . More likely, it will just challenge the ingenuity of patients."

Swirsky said there is simply no evidence yet to suggest smart pills benefit patients and that using the technology outside of clinical trials "flies in the face of the research we do currently have, which shows that patients benefit by receiving care from providers who can manage the many issues around adherence."

"Smart pills are a dangerous reduction of the provider-patient relationship and there is no shortcut to improving , which happens in a larger framework of home, work and clinical environments, not to mention perceptions and emotions," Swirsky said. "This technology dumbs down an issue that is often very complex in the hopes of quickly solving an expensive medical challenge."

For example, the first FDA-approved smart is being used in patients with schizophrenia, who often suffer from paranoia about being surveilled and distrust of medication or care providers. Swirsky said the intent to improve medication adherence in this group of patients is understandable, given that many patients see remarkable benefits from consistent medication use, but it is arguably unethical considering their unique symptoms and vulnerabilities.

The researchers warn that smart pills should be evaluated based on their clinical efficacy against the standard of care drugs, like any other intervention, not based only on compliance or cost savings.

Swirsky co-authored the paper with his UIC colleague Andrew Boyd, who says that when it comes to , "we need to think about the long game."

"It's not just about return on investment—it's about using technology and data in a way that changes lives for the better," said Boyd, associate professor of biomedical and health information sciences in the UIC College of Applied Health Sciences. "There is nothing more personal than our health, and as care strives for high-tech innovation, we cannot do it at the expense of trust between provider and patient."

Use of this type of data-based technology, Boyd said, should also not outpace public policy and legislation in properly regulating how this data is shared, used or purchased by companies.

"Health information technology functions best when implemented in conjunction with doctors and patients in a collaborative manner," the researchers write. "With no magic pill to cure the ills of the modern doctor-patient relationship, patients would be better served by providers who seek a comprehensive understanding of adherence than those who employ they do not understand."

Explore further: Sensor-equipped pill raises technological, ethical questions

More information: Eric S. Swirsky et al, Adherence, Surveillance, and Technological Hubris, The American Journal of Bioethics (2018). DOI: 10.1080/15265161.2018.1498953

Related Stories

Sensor-equipped pill raises technological, ethical questions

November 17, 2017
The first drug with a sensor embedded in a pill that alerts doctors when patients have taken their medications was approved by the Food and Drug Administration, raiding issues involving privacy, cost, and whether patients ...

What is shared decision-making and how does it work for allergists?

September 7, 2018
If you and your doctor chat for a few minutes about treatment options for your allergy symptoms, is that considered shared decision-making (SDM)? It is not, according to a new article published in Annals of Allergy, Asthma ...

New digital pill raises personal privacy concerns

December 28, 2017
The U.S. Food and Drug Administration recently approved a new digital pill capable of monitoring whether individuals are taking a prescribed medication. People not taking their medications – especially those with chronic ...

US regulators approve first digital pill to track patients

November 14, 2017
U.S. regulators have approved the first drug with a sensor that alerts doctors when the medication has been taken, offering a new way of monitoring patients but also raising privacy concerns.

Digital mental health drug raises troubling questions

June 14, 2018
Moments after Neo eats the red pill in The Matrix, he touches a liquefied mirror that takes over his skin, penetrating the innards of his body with computer code. When I first learned about the controversial new digital drug ...

Physicians don't adequately monitor patients' medication adherence

July 16, 2012
Patients' non-adherence to prescribed medication costs the U.S. health care system an estimated $290 billion annually and can lead to poor clinical outcomes, increased hospitalizations and higher mortality.

Recommended for you

Receiving genetic information can change risk

December 11, 2018
Millions of people in the United States alone have submitted their DNA for analysis and received information that not only predicts their risk for disease but, it turns out, in some cases might also have influenced that risk, ...

Effect of oral alfacalcidol on clinical outcomes in patients without secondary hyperparathyroidism

December 11, 2018
Treatment with active vitamin D did not decrease cardiovascular events in kidney patients undergoing hemodialysis, according to a research group in Japan. They have reported their research results in the December 11 issue ...

Yes please to yoghurt and cheese: The new improved Mediterranean diet

December 11, 2018
Thousands of Australians can take heart as new research from the University of South Australia shows a dairy-enhanced Mediterranean diet will significantly increase health outcomes for those at risk of cardiovascular disease ...

Licence to Swill: James Bond's drinking over six decades

December 10, 2018
He may be licensed to kill but fictional British secret service agent James Bond has a severe alcohol use disorder, according to an analysis of his drinking behaviour published in the Medical Journal of Australia's Christmas ...

Obesity, risk of cognitive dysfunction? Consider high-intensity interval exercise

December 10, 2018
It's fast-paced, takes less time to do, and burns a lot of calories. High-intensity interval exercise is widely recognized as the most time-efficient and effective way to exercise. In a first-of-its-kind study, researchers ...

How to survive on 'Game of Thrones': Switch allegiances

December 9, 2018
Characters in the Game of Thrones TV series are more likely to die if they do not switch allegiance, and are male, according to an article published in the open access journal Injury Epidemiology.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.